Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)
China flag China · Delayed Price · Currency is CNY
13.21
+0.06 (0.46%)
Apr 29, 2026, 3:04 PM CST

SHE:300401 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,5181,0321,2841,503554.91502.09
Trading Asset Securities
120.46301.22140.25--0.4
Cash & Short-Term Investments
1,6391,3341,4251,503554.91502.49
Cash Growth
30.41%-6.39%-5.20%170.83%10.43%-63.08%
Accounts Receivable
141.17234.9157.7492.78169.6690.46
Other Receivables
1.415.310.730.81.210.41
Receivables
142.57250.21158.4793.57170.8790.87
Inventory
758.12750.08838.23780.04545.87429.94
Other Current Assets
48.1482.447.9985.56115.3788.07
Total Current Assets
2,5882,4162,4692,4621,3871,111
Property, Plant & Equipment
3,0492,9922,7872,4552,4322,119
Other Intangible Assets
218.88213.87182.73172.23165.77165.87
Long-Term Accounts Receivable
--0.03---
Long-Term Deferred Tax Assets
40.0135.6436.2740.4119.7611.51
Long-Term Deferred Charges
58.9257.7226.5224.5225.4616.61
Other Long-Term Assets
54.5166.53110.86106.01101.97105.67
Total Assets
6,0095,7825,6135,2614,1323,530
Accounts Payable
301.73328.88340.54327.87443.02329.59
Accrued Expenses
13.4842.8763.1450.4260.8347.21
Short-Term Debt
585.41431.4462.79408.68532.39414.37
Current Portion of Long-Term Debt
258.2360.03198.16254.51--
Current Portion of Leases
--0.1--0.2
Current Income Taxes Payable
26.1941.8223.4116.5618.515.32
Current Unearned Revenue
16.899.6921.2619.5555.0334.87
Other Current Liabilities
40.5643.42165.27186.08199.2956.78
Total Current Liabilities
1,242958.121,2751,2641,309898.34
Long-Term Debt
1,1481,2581,054923.27--
Long-Term Unearned Revenue
36.3437.8130.3342.5263.668.86
Long-Term Deferred Tax Liabilities
40.0338.7734.9944.660.370.06
Other Long-Term Liabilities
---93.33186.66279.99
Total Liabilities
2,4672,2932,3942,3671,5601,247
Common Stock
543.69543.47543.47551.01551.01551.01
Additional Paid-In Capital
-49.95-52.91---2
Retained Earnings
2,7902,7402,4972,2262,1111,830
Treasury Stock
---26.86-140.42-53.72-100
Comprehensive Income & Other
257.77258.41204.58256.07-36.37-
Total Common Equity
3,5423,4893,2182,8932,5722,283
Minority Interest
-0.01-0.01-0---
Shareholders' Equity
3,5423,4893,2182,8932,5722,283
Total Liabilities & Equity
6,0095,7825,6135,2614,1323,530
Total Debt
1,9921,7491,7151,586532.39414.57
Net Cash (Debt)
-353.19-415.78-290.6-83.5922.5287.93
Net Cash Growth
-----74.39%-92.15%
Net Cash Per Share
-0.59-0.70-0.49-0.140.040.16
Filing Date Shares Outstanding
558.57544.63534.68542.23559.82543.33
Total Common Shares Outstanding
558.57544.63534.68542.23559.82543.33
Working Capital
1,3451,4581,1951,19877.97213.04
Book Value Per Share
6.346.416.025.344.594.20
Tangible Book Value
3,3233,2753,0362,7212,4062,117
Tangible Book Value Per Share
5.956.015.685.024.303.90
Buildings
--1,4731,3771,180490.73
Machinery
--1,149938.79844.74360.6
Construction In Progress
--661.13504.59672.131,479
Source: S&P Global Market Intelligence. Standard template. Financial Sources.